NASDAQ:NAKA · NASDAQ Global Market
+$0.00 today
Vol 0.22M · Avg 0.24M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Company filings are the primary source for understanding what changed inside Nakamoto Inc. before the market fully reacts. Review recent NAKA disclosures alongside price history and peer context to identify new risks, accounting changes, strategic updates, capital allocation decisions, and operating details that may affect the intrinsic value case.
Price History
Dividend-adjusted closing price
Change
-99.30%
Period High
$600.80
Period Low
$3.37
Latest
$3.37
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Agilon Health, Inc.
NYSE:AGL
$1.85B
Delcath Systems, Inc.
NASDAQ:DCTH
$455.69M
DBV Technologies S.A.
NASDAQ:DBVT
$378.44M
Simulations Plus, Inc.
NASDAQ:SLP
$371.58M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$367.75M
Amarin Corporation plc
NASDAQ:AMRN
$338.58M
Cellectis S.A.
NASDAQ:CLLS
$331.38M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$327.84M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$278.98M
Definitive Healthcare Corp.
NASDAQ:DH
$82.28M
What is the latest NAKA filing?
The latest filing shown is 8-K dated Jun 22, 2026.
How many recent filings does NAKA have?
Intrinsic Alpha currently shows 20 recent filings for NAKA.
Explore More
Continue the stock analysis
Jump to another research area for this company.